Overview of NICE’s Elranatamab Managed Ac...

By João L. Carapinha

October 29, 2024

NICE recently recommended Elranatamab as an option for treating relapsed and refractory multiple myeloma in adults with a man...
Innovative Pricing and Payment Models for Health Technologies
August 2024 Analysis of Türkiye’s Pharmaceutical Foreign Trade
NICE Collaborates with Menarini to Evaluate Elacestrant Breast Cancer Treatment
Enhancing Global Health through Regulatory Collaboration
Strategic Phased Launch of Tirzepatide for Obesity Treatment in England
The Trump Drug Policy Change: A Reverse Course
The Economic Impact of Obesity in Türkiye: A Micro-Costing Analysis
Addressing the Challenges of Value Attribution in Combination Therapies
Global Disparities in Pneumonia Vaccine Access
Health Economic Assessment of Nirsevimab for Respiratory Syncytial Virus in H...
Game-Changer in Atopic Dermatitis Care: Abrocitinib’s Cost-Effectivenes...
The Role of Real-World Evidence in CMS Price Negotiations